Novodiax Webinar Slides:
Rapid Immunodetection in Clinical & Pharmaceutical Applications
Rapid Immunodetection In Clinical and Pharmaceutical Applications Webinar
Jianfu Wang, PhD is President and CEO of Novodiax and an inventor of the polyHPR technology that is driving faster immunohistochemistry tests.
Novodiax is working to provide meaningful improvements to patient care via these rapid technologies which are being applied today to such environments as; breast cancer testing, lymph node dissections, Mohs Micrographic Surgery or Covid testing to provide relevant information at the time of care.
Novodiax rapid immunoassay solutions Include:
New CoNAbTM lateral flow test measures an individual’s neutralizing antibodies to the SARS-CoV-2.
Rapid ihcDirect assays simplify test workflows and speed results for differential diagnosis and surgical margins.
Superior next generation Companion Diagnostics (CDx) may help provide one day diagnosis for targeted therapies.
Q-STAIN® X Autostainer, a rapid, compact, yet simple slide staining system as mainstay in small labs or a specialty system for larger labs.
Jianfu Wang, PhD
Complete this form to view the webinar slides and submit any questions you may have